12 results
8-K
EX-3.1
GBT
Global Blood Therapeutics Inc.
5 Oct 22
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-3.2
GBT
Global Blood Therapeutics Inc.
5 Oct 22
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-3.1
GBT
Global Blood Therapeutics Inc.
8 Aug 22
Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Proposed acquisition drives growth by bringing leading sickle cell disease expertise, portfolio
6:56am
S-1/A
EX-3.7
GBT
Global Blood Therapeutics Inc.
31 Jul 15
IPO registration (amended)
12:00am
S-1/A
EX-3.4
GBT
Global Blood Therapeutics Inc.
31 Jul 15
IPO registration (amended)
12:00am
S-1/A
EX-3.2
039wh degen7dvj8k
31 Jul 15
IPO registration (amended)
12:00am
S-1/A
EX-3.5
9liy 7pd5avlf24g7
31 Jul 15
IPO registration (amended)
12:00am
S-1/A
EX-3.6
6r3ih
31 Jul 15
IPO registration (amended)
12:00am
S-1
EX-3.1
57d2iwj8
8 Jul 15
IPO registration
12:00am
S-1
EX-3.3
n56oknb8p
8 Jul 15
IPO registration
12:00am
DRS
EX-3
8a4lq rx95ukpjas
19 Mar 15
Draft registration statement
12:00am
DRS
EX-3
tth52kom3
19 Mar 15
Draft registration statement
12:00am
- Prev
- 1
- Next